Skip to content

Clinical trials

Phase 3 Acute Coronary Syndrome trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Acute Coronary Syndrome Phase: Phase 3 Country / region: Poland Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20071
20082
20094
20105
20111
20141
20161
20181
20222
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated3
Unknown status3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi3
AstraZeneca2
Collegium Medicum w Bydgoszczy2
Eli Lilly and Company2
GlaxoSmithKline2
Amarin Pharma Inc.1
Anthera Pharmaceuticals1
Bristol-Myers Squibb1
CSL Behring1
Cogentus Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Acute Coronary Syndrome23
Myocardial Infarction6
Non-ST Elevated Myocardial Infarction6
Cardiovascular Diseases5
Heart Diseases5
ST Elevation Myocardial Infarction5
Angina, Unstable4
Coronary Artery Disease4
Myocardial Ischemia3
Stroke3

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.